Antibody seroprevalence in the epicenter Wuhan, Hubei, and six selected provinces after containment of the first epidemic wave of COVID-19 in China

Li, ZJ; Guan, XH; Mao, NY; Luo, HM; Qin, Y; He, N; Zhu, Z; Yu, JX; Li, Y; Liu, JH; An, ZJ; Gao, WJ; Wang, XL; Sun, XD; Song, T; Yang, XF; Wu, M; Wu, XP; Yao, WQ; Peng, ZB; Sun, JL; Wang, LP; Guo, Q; Xiang, NJ; Liu, J; Zhang, BK; Su, XM; Rodewald, L; Li, LM; Xu, WB; Shen, HB; Feng, ZJ; Gao, GF

Feng, ZJ; Gao, GF (corresponding author), Chinese Ctr Dis Control & Prevent China CDC, Beijing, Peoples R China.; Xu, WB (corresponding author), Natl Inst Viral Dis Control & Prevent China CDC, Beijing, Peoples R China.; Shen, HB (corresponding author), Nanjing Med Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Nanjing, Jiangsu, Peoples R China.; Li, LM (corresponding author), Peking Univ, Sch Publ Hlth, Dept Epidemiol & Biostat, Hlth Sci Ctr, Beijing, Peoples R China.

LANCET REGIONAL HEALTH-WESTERN PACIFIC, 2021; 8 ():

Abstract

Background: China implemented containment measures to stop SARS-CoV-2 transmission in response to the COVID-19 epidemic. After the first epidemic wave......

Full Text Link